Pneumococcal conjugate second or third-dose vaccines (PCVc) in Chad
Chad: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 49.0% in 2025. ◆ Volatile
Latest (2025)
49.0%
World rank
156th
of 194 countries
All-time high
49.0%
in 2025
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Chad, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Chad is 49.0%, measured in 2025. That is the highest value across all 18 years on record.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Chad peaked at 49.0% in 2025 and was at its lowest, 0.0%, in 2008.
Chad ranks 156th of 194 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Chad, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2020 | 0.0% | — |
| 2021 | 0.0% | — |
| 2022 | 0.0% | — |
| 2023 | 0.0% | — |
| 2024 | 0.0% | — |
| 2025 | 49.0% | — |
Chad compared with similar countries
- Chad's 49.0% is below the median for low income countries, which is 80.0%, 61% of the median. (25 countries reporting)
- Chad's 49.0% is below the median for Sub-Saharan Africa, which is 82.5%, 59% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 8.2% | 0.0% | 49.0% | 6 |
Countries ranked near Chad
- 153 Angola 54.0% compare
- 153 Iran 54.0% compare
- 155 Azerbaijan 52.0% compare
- 156 Kazakhstan 49.0% compare
- 158 Central African Republic 45.0% compare
- 159 Papua New Guinea 44.0% compare
More health data for Chad
- Un projection of annual infant deaths, annual growth rate -0.9964 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6578 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,071 deaths per 1,000 people (2090)
- Number of infants who die before age 1 41,435 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 245 (2025)
- Population ages 00-04, female, annual growth rate 3.76 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0898 units per person (2025)
- Population ages 00-04, male, annual growth rate 3.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Chad?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Chad was 49.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Chad?
- The highest recorded value was 49.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Chad?
- The lowest recorded value was 0.0% in 2008.
- How does Chad rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Chad ranks 156th out of 194 countries with data for 2025.
- Where does this Chad data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).